Moderna's stock has seen a significant rally due to renewed focus on hantavirus research, driven by public concern over a potential pandemic linked to a cruise ship outbreak.
Impact: The heightened focus on hantavirus research could lead to increased investment in pharmaceutical companies working on relevant treatments or vaccines.
Not investment advice